Compare Bristol-Myers Squibb Co (BMY) vs Elastic NV (ESTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Elastic NV — how do they compare? Bristol-Myers Squibb Co trades at $63.61 (market cap $129.94B), while Elastic NV trades at $75.22 (market cap $7.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 16.4× Elastic NV's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Elastic NV pays none. Which is the better fit depends on your goals.
| BMY | ESTC | |
|---|---|---|
Market Cap | $129.94B | $7.94B |
Sector | Health | Technology |
52-Week High | $65.89 | $94.47 |
52-Week Low | $42.60 | $43.30 |
Enterprise Value | $163.92B | $7.16B |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →
